Coronavirus Update: 'Positive News' Imminent From Oxford and AstraZeneca Vaccine

Plus: Favipiravir Price Cut And New Approval In India

 
• By Scrip Team
  
Old Road Campus
The vaccine is being developed by Oxford's Jenner Institute in collaboration with AstraZeneca
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip